For example, KRAS inhibitors have been reported to enhance cancer cell antigen processing, antigen presentation to T cells, and reprogram tumor-associated myeloid cells to assist cancer-specific T cells to traffic and function within tumors (52). Here, KRAS is linked to cancer.